Acute_JJ Septic_NP Arthritis_NP Acute_NP septic_JJ arthritis_NN may_MD develop_VB as_IN a_DT result_NN of_IN hematogenous_JJ seeding_VBG ,_, direct_JJ introduction_NN ,_, or_CC extension_NN from_IN a_DT contiguous_JJ focus_NN of_IN infection_NN ._SENT The_DT pathogenesis_NN of_IN acute_JJ septic_JJ arthritis_NN is_VBZ multifactorial_JJ and_CC depends_VBZ on_IN the_DT interaction_NN of_IN the_DT host_NN immune_JJ response_NN and_CC the_DT adherence_NN factors_NNS ,_, toxins_NNS ,_, and_CC immunoavoidance_NN strategies_NNS of_IN the_DT invading_VBG pathogen_NN ._SENT Neisseria_NN gonorrhoeae_NNS and_CC Staphylococcus_NP aureus_NN are_VBP used_VBN in_IN discussing_VBG the_DT host-pathogen_NN interaction_NN in_IN the_DT pathogenesis_NN of_IN acute_JJ septic_JJ arthritis_NN ._SENT While_IN diagnosis_NN rests_NNS on_IN isolation_NN of_IN the_DT bacterial_JJ species_NN from_IN synovial_JJ fluid_JJ samples_NNS ,_, patient_JJ history_NN ,_, clinical_JJ presentation_NN ,_, laboratory_NN findings_NNS ,_, and_CC imaging_NN studies_NNS are_VBP also_RB important_JJ ._SENT Acute_JJ nongonococcal_JJ septic_JJ arthritis_NN is_VBZ a_DT medical_JJ emergency_NN that_WDT can_MD lead_VB to_TO significant_JJ morbidity_NN and_CC mortality_NN ._SENT Therefore_RB ,_, prompt_JJ recognition_NN ,_, rapid_JJ and_CC aggressive_JJ antimicrobial_JJ therapy_NN ,_, and_CC surgical_JJ treatment_NN are_VBP critical_JJ to_TO ensuring_VBG a_DT good_JJ prognosis_NN ._SENT Even_RB with_IN prompt_JJ diagnosis_NN and_CC treatment_NN ,_, high_JJ mortality_NN and_CC morbidity_NN rates_NNS still_RB occur_VBP ._SENT In_IN contrast_NN ,_, gonococcal_JJ arthritis_NN is_VBZ often_RB successfully_RB treated_VBN with_IN antimicrobial_JJ therapy_NN alone_RB and_CC demonstrates_VBZ a_DT very_RB low_JJ rate_NN of_IN complications_NNS and_CC an_DT excellent_JJ prognosis_NN for_IN full_JJ return_NN of_IN normal_JJ joint_JJ function_NN ._SENT In_IN the_DT case_NN of_IN prosthetic_JJ joint_JJ infections_NNS ,_, the_DT hardware_NN must_MD be_VB eventually_RB removed_VBN by_IN a_DT two-stage_NP revision_NN in_IN order_NN to_TO cure_VB the_DT infection_NN ._SENT Most_RBS septic_JJ joints_NNS develop_VBP as_IN a_DT result_NN of_IN hematogenous_JJ seeding_VBG of_IN the_DT vascular_JJ synovial_JJ membrane_NN due_JJ to_TO a_DT bacteremic_JJ episode_NN ._SENT Although_IN a_DT rare_JJ cause_NN ,_, acute_JJ septic_JJ arthritis_NN may_MD also_RB occur_VB as_IN a_DT result_NN of_IN joint_JJ aspiration_NN or_CC local_JJ corticosteroid_NN joint_JJ injection_NN ._SENT In_IN addition_NN ,_, bacterial_JJ arthritis_NN may_MD arise_VB secondary_JJ to_TO penetrating_VBG trauma_NN (_( such_JJ as_IN human_JJ or_CC animal_JJ bite_NN or_CC nail_NN puncture_NN )_) or_CC after_IN trauma_NN to_TO a_DT joint_NN without_IN an_DT obvious_JJ break_NN in_IN the_DT skin_NN ._SENT The_DT direct_JJ introduction_NN of_IN bacteria_NNS during_IN joint_JJ surgery_NN has_VBZ increasingly_RB been_VBN a_DT source_NN of_IN bacterial_JJ arthritis_NN ,_, particularly_RB in_IN association_NN with_IN knee_NN and_CC hip_NN arthroplasties_NNS ._SENT When_WRB a_DT bone_NN infection_NN breaks_VBZ through_IN the_DT outer_JJ cortex_NN and_CC into_IN the_DT intracapsular_JJ region_NN ,_, a_DT joint_JJ infection_NN may_MD also_RB result_VB ,_, especially_RB in_IN children_NNS ._SENT In_IN infants_NNS ,_, small_JJ capillaries_NNS cross_VBP the_DT epiphyseal_JJ growth_NN plate_NN and_CC permit_VB extension_NN of_IN infection_NN into_IN the_DT epiphysis_NN and_CC joint_JJ space_NN ._SENT In_IN children_NNS older_JJR than_IN 1_CD year_NN ,_, osteomyelitis_NN infection_NN presumably_RB starts_VBZ in_IN the_DT metaphyseal_JJ sinusoidal_JJ veins_NNS and_CC is_VBZ usually_RB contained_VBN by_IN the_DT growth_NN plate_NN ._SENT The_DT joint_NN is_VBZ spared_VBN unless_IN the_DT metaphysis_NN is_VBZ intracapsular_JJ ._SENT The_DT infection_NN spreads_VBZ laterally_RB ,_, where_WRB it_PP breaks_VBZ through_IN the_DT cortex_NN and_CC lifts_VBZ the_DT loose_JJ periosteum_NN to_TO form_VB a_DT subperiosteal_JJ abscess_NN ._SENT In_IN adults_NNS ,_, the_DT growth_NN plate_NN has_VBZ resorbed_VBN and_CC the_DT infection_NN may_MD again_RB extend_VB to_TO the_DT joint_JJ spaces_NNS ._SENT Virtually_RB every_DT bacterial_JJ organism_NN has_VBZ been_VBN reported_VBN to_TO cause_VB septic_JJ arthritis_NN ._SENT The_DT microorganisms_NNS responsible_JJ for_IN bacterial_JJ arthritis_NN are_VBP largely_RB dependent_JJ on_IN host_NN factors_NNS (_( see_VB "_`` Risk_NP Factors_NP "_'' below_IN )_) ._SENT The_DT most_RBS common_JJ etiological_JJ agent_NN of_IN all_DT septic_JJ arthritis_NN cases_NNS in_IN Europe_NP and_CC all_DT nongonococcal_JJ cases_NNS in_IN the_DT United_NP States_NPS is_VBZ Staphylococcus_NP aureus_NN ._SENT The_DT representation_NN of_IN S._NP aureus_NN is_VBZ more_RBR pronounced_VBN in_IN patients_NNS with_IN either_DT rheumatoid_JJ arthritis_NN or_CC diabetes_NN ._SENT After_IN S._NP aureus_NN ,_, Streptococcus_NP spp._NP are_VBP the_DT next_JJ most_RBS commonly_RB isolated_VBN bacteria_NNS from_IN adult_JJ patients_NNS with_IN septic_JJ arthritis_NN ._SENT While_IN one_CD study_NN had_VBD a_DT high_JJ representation_NN of_IN Streptococcus_NP pneumoniae_NNS ,_, Streptococcus_NP pyogenes_NNS is_VBZ usually_RB the_DT most_RBS common_JJ streptococcal_JJ isolate_NN ,_, often_RB associated_VBN with_IN autoimmune_JJ diseases_NNS ,_, chronic_JJ skin_NN infections_NNS ,_, and_CC trauma_NN ._SENT Groups_NNS B_NP ,_, G_NP ,_, C_NP ,_, and_CC F_NP ,_, in_IN order_NN of_IN decreasing_VBG preponderance_NN ,_, are_VBP also_RB isolated_VBN ,_, especially_RB in_IN patients_NNS with_IN immunocompromise_NN ,_, diabetes_NN mellitus_NN ,_, malignancy_NN ,_, and_CC severe_JJ genitourinary_JJ or_CC gastrointestinal_JJ infections_NNS ._SENT Gram-negative_JJ bacilli_NNS account_VBP for_IN approximately_RB 10_CD to_TO 20_CD %_NN of_IN cases_NNS ._SENT Patients_NNS with_IN a_DT history_NN of_IN intravenous_JJ drug_NN abuse_NN ,_, extremes_NNS of_IN age_NN ,_, or_CC immunocompromise_NN display_VBP a_DT higher_JJR prevalence_NN of_IN infection_NN by_IN gram-negative_JJ organisms_NNS ._SENT The_DT most_RBS common_JJ gram-negative_JJ organisms_NNS are_VBP Pseudomonas_NP aeruginosa_NP and_CC Escherichia_NP coli_NNS ._SENT Anaerobes_NNS are_VBP also_RB isolated_VBN in_IN a_DT small_JJ percentage_NN of_IN cases_NNS ,_, usually_RB in_IN diabetic_JJ patients_NNS and_CC patients_NNS with_IN prosthetic_JJ joints_NNS ._SENT Approximately_RB 10_CD %_NN of_IN patients_NNS with_IN nongonococcal_JJ septic_JJ arthritis_NN have_VBP polymicrobial_JJ infections_NNS ._SENT Historically_RB ,_, Haemophilus_NP influenzae_NP ,_, S._NP aureus_NN ,_, and_CC group_NN A_DT streptococci_NNS were_VBD the_DT most_RBS common_JJ causes_NNS of_IN infectious_JJ arthritis_NN in_IN children_NNS younger_JJR than_IN 2_CD years_NNS ._SENT However_RB ,_, the_DT overall_JJ incidence_NN of_IN H._NP influenzae_NP as_IN a_DT cause_NN of_IN septic_JJ arthritis_NN is_VBZ decreasing_VBG because_IN of_IN the_DT H._NP influenzae_NP type_NN b_NN (_( Hib_NP )_) vaccine_NN now_RB given_VBN to_TO children_NNS ._SENT A_DT recent_JJ study_NN of_IN 165_CD cases_NNS of_IN acute_JJ hematogenous_JJ osteomyelitis_NN or_CC septic_JJ arthritis_NN treated_VBN in_IN the_DT years_NNS before_IN and_CC after_IN the_DT advent_NN of_IN the_DT Hib_NP vaccine_NN demonstrated_VBD that_IN musculoskeletal_JJ infections_NNS due_JJ to_TO this_DT bacterial_JJ species_NN were_VBD reduced_VBN to_TO nearly_RB nonexistent_JJ levels_NNS ._SENT Therefore_RB ,_, the_DT coverage_NN of_IN H._NP influenzae_NP as_IN part_NN of_IN the_DT empiric_JJ antibiotic_JJ coverage_NN may_MD no_RB longer_RBR be_VB needed_VBN in_IN the_DT management_NN of_IN acute_JJ septic_JJ arthritis_NN in_IN Hib-vaccinated_JJ children_NNS ._SENT While_IN H._NP influenzae_NP has_VBZ lost_VBN its_PP$ predominance_NN as_IN the_DT most_RBS commonly_RB identified_VBN gram-negative_JJ pathogen_NN in_IN pediatric_JJ populations_NNS ,_, the_DT normal_JJ oropharyngeal_JJ resident_NN of_IN young_JJ children_NNS ,_, Kingella_NP kingae_NNS ,_, may_MD have_VB taken_VBN its_PP$ place_NN ,_, specifically_RB in_IN patients_NNS younger_JJR than_IN 2_CD year_NN ._SENT In_IN fact_NN ,_, a_DT recent_JJ study_NN found_VBD that_IN the_DT nearly_RB half_JJ of_IN the_DT clinical_JJ isolates_NNS from_IN patients_NNS younger_JJR than_IN 2_CD years_NNS with_IN acute_JJ septic_JJ arthritis_NN were_VBD K._NP kingae_NNS ._SENT However_RB ,_, these_DT results_NNS have_VBP yet_RB to_TO be_VB repeated_VBN in_IN other_JJ regions_NNS ._SENT Clinical_JJ data_NNS suggest_VBP that_IN the_DT organism_NN may_MD gain_VB access_NN to_TO the_DT bloodstream_NN in_IN the_DT course_NN of_IN an_DT upper_JJ respiratory_JJ infection_NN or_CC stomatitis_NN ._SENT In_IN children_NNS older_JJR than_IN 2_CD years_NNS ,_, S._NP aureus_NN ,_, streptococci_NNS ,_, H._NP influenzae_NP ,_, and_CC N._NP gonorrhoea_NN have_VBP usually_RB been_VBN isolated_VBN ,_, although_IN H._NP influenzae_NP may_MD have_VB also_RB lost_VBN its_PP$ predominance_NN in_IN patients_NNS in_IN this_DT age_NN group_NN ._SENT Microbiological_JJ associations_NNS exist_VBP with_IN concomitant_JJ disease_NN states_NNS ._SENT Septic_JJ arthritis_NN following_VBG cases_NNS of_IN infectious_JJ diarrhea_NN may_MD be_VB caused_VBN by_IN Shigella_NP spp._NP ,_, Salmonella_NP spp._NP ,_, Campylobacter_NP spp._NP ,_, or_CC Yersinia_NP spp._NP ._SENT However_RB ,_, these_DT cases_NNS may_MD reflect_VB a_DT form_NN of_IN reactive_JJ arthritis_NN ._SENT A_DT rare_JJ form_NN of_IN migrating_VBG polyarthritis_NN may_MD be_VB caused_VBN by_IN Streptobacillus_NP moniliformis_NNS ._SENT In_IN human_JJ immunodeficiency_NN virus_NN (HIV)-infected_JJ patients_NNS ,_, S._NP aureus_NN continues_VBZ to_TO be_VB the_DT most_RBS common_JJ isolate_NN (_( approximately_RB 30_CD %_NN )_) ._SENT However_RB ,_, increased_VBD numbers_NNS of_IN opportunistic_JJ pathogens_NNS are_VBP isolated_VBN from_IN this_DT patient_JJ subset_NN ,_, including_VBG S._NP pneumoniae_NNS ,_, mycobacterial_JJ species_NNS ,_, and_CC fungal_JJ species_NNS ._SENT While_IN relatively_RB rare_JJ in_IN Western_NP Europe_NP ,_, the_DT diplococcus_NN gram-negative_JJ bacterial_JJ species_NNS Neisseria_NP gonorrhoeae_NNS is_VBZ the_DT most_RBS common_JJ cause_NN of_IN septic_JJ arthritis_NN in_IN United_NP States_NPS ._SENT The_DT number_NN of_IN cases_NNS of_IN gonorrhea_NN decreased_VBN by_IN 72_CD %_NN between_IN 1975_CD and_CC 1997_CD ,_, and_CC this_DT decrease_NN was_VBD correlated_VBN with_IN a_DT reduction_NN in_IN disseminated_VBN gonococcal_JJ infection_NN and_CC arthritis_NN ._SENT However_RB ,_, the_DT reported_VBN rate_NN has_VBZ increased_VBN by_IN 9.2_CD %_NN between_IN 1997_CD and_CC 1999_CD and_CC now_RB stands_VBZ at_IN 133.2_CD cases_NNS per_IN 100,000_CD per_IN year_NN ._SENT Specifically_RB ,_, the_DT rate_NN of_IN gonococcal_JJ infection_NN in_IN men_NNS who_WP have_VBP sex_NN with_IN men_NNS has_VBZ demonstrated_VBN an_DT alarming_JJ increase_NN ._SENT These_DT increased_VBN incidence_NN rates_NNS may_MD also_RB cause_VB larger_JJR numbers_NNS of_IN observed_JJ gonococcal_JJ arthritis_NN cases_NNS ._SENT The_DT pathogenesis_NN of_IN acute_JJ septic_JJ arthritis_NN is_VBZ multifactorial_JJ and_CC depends_VBZ on_IN the_DT interaction_NN of_IN the_DT host_NN immune_JJ response_NN and_CC the_DT invading_VBG pathogen_NN ._SENT By_IN taking_VBG into_IN account_NN the_DT steps_NNS of_IN bacterial_JJ colonization_NN ,_, infection_NN and_CC induction_NN of_IN the_DT host_NN inflammatory_JJ response_NN ,_, one_PP may_MD gain_VB a_DT greater_JJR understanding_NN of_IN this_DT joint_JJ disease_NN ._SENT Since_IN S._NP aureus_NN has_VBZ been_VBN extensively_RB studied_VBN with_IN regard_NN to_TO its_PP$ role_NN in_IN septic_JJ arthritis_NN and_CC causes_VBZ the_DT majority_NN of_IN cases_NNS in_IN most_JJS nations_NNS (_( and_CC the_DT majority_NN of_IN nongonococcal_JJ cases_NNS in_IN the_DT United_NP States_NPS )_) ,_, we_PP will_MD use_VB this_DT bacterial_JJ species_NN as_IN the_DT "_`` typical_JJ "_'' pathogen_NN in_IN the_DT discussion_NN of_IN acute_JJ nongonococcal_JJ septic_JJ arthritis_NN ._SENT The_DT synovial_JJ membrane_NN has_VBZ no_DT limiting_VBG basement_NN plate_NN under_IN the_DT well-vascularized_JJ synovium_NN ;_: this_DT allows_VBZ easy_JJ hematogenous_JJ entry_NN of_IN bacteria_NNS ._SENT As_RB mentioned_VBN above_RB ,_, bacteria_NNS may_MD also_RB gain_VB entry_NN into_IN the_DT joint_NN by_IN direct_JJ introduction_NN or_CC extension_NN from_IN a_DT contiguous_JJ site_NN of_IN infection_NN ._SENT Once_RB bacteria_NNS are_VBP seeded_VBN within_IN the_DT closed_JJ joint_JJ space_NN ,_, the_DT low_JJ fluid_JJ shear_NN conditions_NNS enable_VBP bacterial_JJ adherence_NN and_CC infection_NN ._SENT Colonization_NN may_MD also_RB be_VB aided_VBN in_IN cases_NNS where_WRB the_DT joint_NN has_VBZ undergone_VBN recent_JJ injury_NN ._SENT In_IN this_DT environment_NN ,_, the_DT production_NN of_IN host-derived_JJ extracellular_JJ matrix_NN proteins_VBZ that_DT aid_NN in_IN joint_JJ healing_NN (_( e.g._FW ,_, fibronectin_NP )_) may_MD promote_VB bacterial_JJ attachment_NN and_CC progression_NN to_TO infection_NN ._SENT The_DT virulence_NN and_CC tropism_NN of_IN the_DT microorganisms_NNS ,_, combined_VBN with_IN the_DT resistance_NN or_CC susceptibility_NN of_IN the_DT synovium_NN to_TO microbial_JJ invasion_NN ,_, are_VBP major_JJ determinants_NNS of_IN joint_JJ infection_NN ._SENT S._NP aureus_NN ,_, Streptococcus_NP spp._NP ,_, and_CC N._NP gonorrhoeae_NNS are_VBP examples_NNS of_IN bacteria_NNS that_WDT have_VBP a_DT high_JJ degree_NN of_IN selectivity_NN for_IN the_DT synovium_NN ,_, probably_RB related_VBN to_TO adherence_NN characteristics_NNS and_CC toxin_NN production_NN ._SENT Aerobic_JJ gram-negative_JJ bacilli_NNS such_JJ as_IN Escherichia_NP coli_NNS rarely_RB infect_VBP the_DT synovium_NN except_IN in_IN the_DT presence_NN of_IN an_DT underlying_VBG and_CC compromising_VBG condition_NN ._SENT The_DT virulence_NN of_IN the_DT organism_NN once_RB inside_IN the_DT joint_NN varies_VBZ ._SENT In_IN rabbits_NNS ,_, intra-articular_JJ injection_NN of_IN 10_CD 5S_NN ._SENT aureus_NN organisms_NNS into_IN the_DT knee_NN joint_NN resulted_VBN in_IN major_JJ joint_JJ destruction_NN but_CC identical_JJ injections_NNS of_IN N._NP gonorrhoeae_NNS or_CC S._NP epidermidis_NNS caused_VBD no_DT joint_JJ inflammation_NN ._SENT S._NP aureus_NN has_VBZ a_DT variety_NN of_IN receptors_NNS ,_, termed_VBD microbial_JJ surface_NN components_NNS recognizing_VBG adhesive_JJ matrix_NN molecules_NNS (_( MSCRAMMs_NP )_) ,_, for_IN host_NN proteins_NNS that_WDT mediate_VBP adherence_NN to_TO the_DT joint_JJ extracellular_JJ matrix_NN or_CC implanted_VBD medical_JJ devices_NNS ._SENT Some_DT of_IN the_DT host_NN matrix_NN proteins_NNS include_VBP fibronectin_NN and_CC laminin_NN (_( adherence_NN proteins_NNS )_) ,_, elastin_NN (_( imparts_VBZ elastic_JJ properties_NNS )_) ,_, collagen_NN (_( structural_JJ support_NN )_) ,_, and_CC hyaluronic_JJ acid_NN (_( a_DT glycosaminoglycan_NN that_WDT is_VBZ rich_JJ in_IN the_DT joints_NNS and_CC the_DT matrix_NN and_CC provides_VBZ cushioning_NN through_IN hydration_NN of_IN its_PP$ polysaccharides_NNS )_) ._SENT A_DT number_NN of_IN adhesin_NN genes_NNS have_VBP been_VBN determined_VBN and_CC include_VBP genes_NNS encoding_VBG fibrinogen_NN binding_JJ proteins_NNS (_( fib_NN ,_, cflA_NN ,_, and_CC fbpA_NN )_) ,_, fibronectin_JJ binding_JJ proteins_NNS (_( fnbA_NP and_CC fnbB_NP )_) ,_, a_DT collagen_NN receptor_NN (_( cna_NN )_) ,_, an_DT elastin_NN binding_VBG protein_NN (_( ebpS_NNS )_) ,_, and_CC a_DT broad-specificity_NN adhesin_NN (_( map_NN )_) that_WDT mediates_VBZ low-level_JJ binding_NN of_IN several_JJ proteins_NNS including_VBG osteopontin_NN ,_, collagen_NN ,_, bone_NN sialoprotein_NN ,_, vitronectin_NP ,_, fibronectin_NN ,_, and_CC fibrinogen_NN ._SENT Also_RB ,_, S._NP aureus_NN possesses_VBZ a_DT number_NN of_IN other_JJ host_NN protein_NN binding_JJ receptors_NNS whose_WP$ genes_NNS have_VBP not_RB yet_RB been_VBN determined_VBN ._SENT These_DT include_VBP a_DT laminin_NN binding_VBG protein_NN (_( 52_CD kDa_NNS )_) ,_, a_DT lactoferrin_NN binding_VBG protein_NN (_( 450_CD kDa_NNS )_) ,_, and_CC a_DT transferrin_NN binding_VBG protein_NN (_( 42_CD kDa_NN )_) ._SENT The_DT staphylococcal_JJ receptor_NN that_WDT binds_VBZ laminin_NN may_MD be_VB used_VBN in_IN extravasation_NN ._SENT These_DT receptors_NNS specific_JJ to_TO S._NP aureus_NN were_VBD absent_JJ from_IN the_DT noninvasive_JJ pathogen_NN S._NP epidermidis_NNS ._SENT The_DT lactoferrin_NN and_CC transferrin_NN receptors_NNS bind_VBP to_TO host_VB iron_NN acquisition_NN proteins_NNS and_CC may_MD be_VB used_VBN as_IN adhesins_NNS and/or_CC as_RB iron_VB acquisition_NN mechanisms_NNS ._SENT Increasing_VBG evidence_NN supports_VBZ the_DT importance_NN of_IN staphylococcal_JJ surface_NN components_NNS as_IN virulence_NN determinants_NNS by_IN enabling_VBG initial_JJ colonization_NN ._SENT In_IN a_DT number_NN of_IN studies_NNS ,_, mutations_NNS in_IN these_DT receptors_NNS strongly_RB reduced_VBD the_DT ability_NN of_IN staphylococci_NNS to_TO produce_VB infection_NN ._SENT In_IN a_DT murine_JJ septic_JJ arthritis_NN model_NN ,_, inoculation_NN of_IN mice_NNS with_IN mutants_NNS containing_VBG mutations_NNS of_IN the_DT collagen_NN adhesin_NN gene_NN showed_VBD that_IN septic_JJ arthritis_NN occurred_VBD 43_CD %_NN less_JJR often_RB than_IN in_IN the_DT corresponding_JJ wild_JJ type_NN ._SENT Also_RB ,_, vaccination_NN with_IN a_DT recombinant_JJ fragment_NN of_IN the_DT S._NP aureus_NN collagen_NN adhesin_NN was_VBD able_JJ to_TO reduce_VB the_DT sepsis-induced_JJ mortality_NN rate_NN to_TO 13_CD %_NN ,_, compared_VBN with_IN 87_CD %_NN in_IN the_DT control_NN group_NN ._SENT However_RB ,_, the_DT role_NN of_IN collagen_NN adhesion_NN of_IN S._NP aureus_NN as_IN a_DT major_JJ virulence_NN factor_NN has_VBZ recently_RB been_VBN questioned_VBN since_IN approximately_RB 30_CD to_TO 60_CD %_NN of_IN clinical_JJ isolates_NNS do_VBP not_RB display_VB collagen_NN binding_VBG in_IN vitro_NN or_CC the_DT cna-encoded_JJ collagen_NN adhesin_NN ._SENT Staphyloccal_JJ fibronectin_NN binding_JJ proteins_NNS (_( FbpA_NP and_CC FbpB_NP )_) may_MD play_VB a_DT major_JJ role_NN in_IN the_DT colonization_NN and_CC virulence_NN of_IN septic_JJ arthritis_NN ._SENT In_IN a_DT recent_JJ study_NN ,_, all_RB of_IN the_DT tested_VBN clinical_JJ isolates_NNS (_( n_NN =_SYM 163_LS )_) contained_VBN one_CD or_CC both_DT of_IN the_DT coding_VBG regions_NNS for_IN these_DT binding_JJ proteins_NNS and_CC 95_CD %_NN of_IN these_DT strains_NNS had_VBD a_DT comparable_JJ fibronectin_NN binding_VBG capacity_NN to_TO that_DT seen_VBN in_IN a_DT staphylococcal_JJ reference_NN strain_NN known_VBN to_TO efficiently_RB bind_VB fibronectin_NN ._SENT In_IN addition_NN ,_, an_DT in_IN vivo_JJ study_NN of_IN endocarditis_NN in_IN a_DT rat_NN model_NN showed_VBD that_IN mutants_NNS deficient_JJ for_IN fibronectin_JJ binding_JJ protein_NN were_VBD 250-fold_JJ less_RBR adherent_JJ to_TO traumatized_VBN heart_NN valves_NNS ._SENT Also_RB ,_, S._NP aureus_NN adherence_NN to_TO miniplates_NNS from_IN iliac_JJ bones_NNS of_IN guinea_NN pigs_NNS was_VBD three_CD times_NNS higher_JJR for_IN the_DT wild-type_NN strain_NN than_IN for_IN the_DT adhesin-defective_JJ mutant_JJ strain_NN ._SENT It_PP is_VBZ likely_RB fibronectin_JJ binding_JJ proteins_NNS play_VBP an_DT important_JJ role_NN in_IN joint_JJ infections_NNS ,_, especially_RB those_DT associated_VBN with_IN joint_JJ trauma_NN or_CC implanted_VBD medical_JJ devices_NNS ._SENT These_DT receptors_NNS may_MD play_VB an_DT additional_JJ role_NN in_IN an_DT intracellular_JJ immunoavoidance_NN strategy_NN ._SENT S._NP aureus_NN survives_VBZ intracellularly_RB after_IN internalization_NN by_IN cultured_JJ osteoblasts_NNS ._SENT Staphylococci_NNS have_VBP demonstrated_VBN internalization_NN into_IN other_JJ cultured_JJ mammalian_JJ cells_NNS as_RB well_RB as_IN osteoblasts_NNS ;_: these_DT include_VBP bovine_JJ mammary_JJ gland_NN epithelial_JJ cells_NNS ,_, human_JJ umbilical_JJ vein_NN endothelial_JJ cells_NNS ,_, and_CC pulmonary_JJ epithelial_JJ cells_NNS isolated_VBN from_IN a_DT cystic_JJ fibrosis_NN patient_NN ._SENT Initial_JJ adherence_NN to_TO glandular_JJ epithelial_JJ cells_NNS is_VBZ mediated_VBN by_IN S._NP aureus_NN fibronectin_NN receptors_NNS ,_, possibly_RB using_VBG fibronectin_NN as_IN a_DT bridge_NN between_IN the_DT host_NN cell_NN and_CC the_DT bacterial_JJ receptors_NNS ._SENT Following_VBG adherence_NN ,_, bacteria_NNS may_MD be_VB internalized_VBN by_IN host_NN mechanisms_NNS involving_VBG membrane_NN pseudopod_NN formation_NN (_( seen_VBN in_IN established_VBN bovine_JJ mammary_JJ epithelial_JJ cell_NN lines_NNS )_) or_CC through_IN receptor-mediated_JJ endocytosis_NN via_IN clathrin-coated_JJ pits_NNS (_( seen_VBN in_IN mouse_NN osteoblasts_NNS and_CC epithelial_JJ cells_NNS )_) ._SENT In_IN either_DT case_NN ,_, the_DT dependence_NN on_IN the_DT action_NN of_IN host_NN cytoskeletal_NN rearrangements_NNS through_IN microfilaments_NNS is_VBZ evident_JJ ._SENT Following_VBG internalization_NN ,_, staphylococci_NNS may_MD induce_VB apoptosis_NN (_( via_IN a_DT host_NN caspase-dependent_NN mechanism_NN )_) or_CC survive_VB intracellularly_RB ._SENT Induced_VBN apoptosis_NN may_MD exacerbate_VB the_DT host_NN cell_NN damage_NN seen_VBN in_IN septic_JJ arthritis_NN ._SENT Also_RB ,_, staphylococci_NNS may_MD escape_VB clearance_NN by_IN the_DT immune_JJ system_NN and_CC antimicrobial_JJ therapy_NN by_IN persisting_VBG within_IN these_DT host_NN cells_NNS ._SENT This_DT survival_NN was_VBD recently_RB demonstrated_VBN in_IN vivo_RB when_WRB S._NP aureus_NN cells_NNS were_VBD found_VBN in_IN the_DT cytoplasm_NN of_IN embryonic_JJ chicken_NN osteoblasts_NNS and_CC osteocytes_NNS in_IN mineralized_VBN bone_NN matrix_NN ._SENT In_IN another_DT study_NN ,_, S._NP aureus_NN was_VBD found_VBN within_IN polymorphonuclear_JJ neutrophils_NNS in_IN an_DT in_IN vivo_JJ infection_NN model_NN ,_, and_CC these_DT infected_JJ host_NN cells_NNS were_VBD able_JJ to_TO establish_VB infection_NN in_IN naive_JJ animals_NNS ._SENT Therefore_RB ,_, this_DT pathogen_NN may_MD utilize_VB invasion_NN as_IN an_DT immunoavoidance_NN technique_NN during_IN the_DT host_NN inflammatory_JJ response_NN ._SENT After_IN the_DT downregulation_NN of_IN the_DT adaptive_JJ immune_JJ response_NN through_IN T-cell_NN apoptosis_NN (_( mediated_VBN by_IN superantigens_NNS ,_, other_JJ toxins_NNS ,_, and_CC invasion_NN )_) ,_, fulminant_JJ and/or_CC persistent_JJ infection_NN may_MD result_VB ._SENT Once_RB colonized_VBN ,_, bacteria_NNS are_VBP able_JJ to_TO rapidly_RB proliferate_VB and_CC activate_VB an_DT acute_JJ inflammatory_JJ response_NN ._SENT Initially_RB ,_, host_VB inflammatory_JJ cytokines_NNS ,_, including_VBG interleukin_NN 1-beta_NP (_( IL-1beta_NP )_) and_CC interleukin_NN 6_CD (_( IL-6_NP )_) ,_, are_VBP released_VBN into_IN the_DT joint_JJ fluid_NN by_IN synovial_JJ cells_NNS ._SENT These_DT cytokines_NNS activate_VBP the_DT release_NN of_IN acute-phase_JJ proteins_NNS (_( e.g._FW ,_, C-reactive_JJ protein_NN )_) from_IN the_DT liver_NN that_IN bind_NN to_TO the_DT bacterial_JJ cells_NNS and_CC thereby_RB promote_VB opsonization_NN and_CC activation_NN of_IN the_DT complement_NN system_NN ._SENT In_IN addition_NN ,_, there_EX is_VBZ an_DT accompanying_JJ influx_NN of_IN host_NN inflammatory_JJ cells_NNS into_IN the_DT synovial_JJ membrane_NN early_RB in_IN the_DT infection_NN ._SENT Phagocytosis_NN of_IN the_DT bacteria_NNS by_IN macrophages_NNS ,_, synoviocytes_NNS ,_, and_CC polymorphonuclear_JJ cells_NNS occurs_VBZ and_CC is_VBZ associated_VBN with_IN the_DT release_NN of_IN other_JJ inflammatory_JJ cytokines_NNS that_WDT include_VBP tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NP )_) ,_, IL-8_NP ,_, and_CC granulocyte-macrophage_NN colony-stimulating_NN factor_NN ,_, in_IN addition_NN to_TO increasing_VBG the_DT levels_NNS of_IN IL-1beta_NP and_CC IL-6_NP ,_, which_WDT are_VBP already_RB present_JJ ._SENT It_PP was_VBD demonstrated_VBN in_IN a_DT recent_JJ clinical_JJ study_NN that_IN IL-6_NP and_CC TNF-alpha_NP concentrations_NNS were_VBD persistently_RB high_JJ even_RB 7_CD days_NNS after_IN treatment_NN was_VBD initiated_VBN while_IN IL-1beta_NP levels_NNS decreased_VBD significantly_RB after_IN 7_CD days_NNS ._SENT Many_JJ of_IN these_DT cytokines_NNS and_CC the_DT associated_JJ immune_JJ response_NN have_VBP been_VBN shown_VBN in_IN animal_JJ models_NNS to_TO be_VB required_VBN for_IN bacterial_JJ clearance_NN and_CC the_DT prevention_NN of_IN mortality_NN due_JJ to_TO bacteremia_NN and_CC septic_JJ shock_NN ._SENT Nitric_JJ oxide_NN ,_, a_DT common_JJ mediator_NN of_IN inflammatory_JJ cytokines_NNS ,_, is_VBZ also_RB required_VBN ._SENT The_DT T-cell_NN mediated_VBN (_( Th1_NP )_) and_CC humoral_JJ (_( Th2_JJ )_) adaptive_JJ immune_JJ responses_NNS may_MD also_RB play_VB a_DT role_NN in_IN the_DT clearance_NN and/or_CC pathogenesis_NN of_IN acute_JJ septic_JJ arthritis_NN ._SENT T_NN cells_NNS enter_VBP the_DT joint_NN within_IN a_DT few_JJ days_NNS following_VBG infection_NN ._SENT The_DT role_NN of_IN CD4_NP +_SYM T_NN cells_NNS in_IN joint_JJ destruction_NN has_VBZ been_VBN demonstrated_VBN by_IN showing_VBG that_IN their_PP$ in_IN vivo_JJ depletion_NN resulted_VBN in_IN a_DT considerably_RB milder_JJR course_NN of_IN staphylococcal_JJ arthritis_NN ._SENT These_DT lymphocytes_NNS are_VBP specifically_RB activated_VBN by_IN bacterial_JJ antigens_NNS in_IN association_NN with_IN host_NN antigen-presenting_NN cells_NNS or_CC nonspecifically_RB in_IN the_DT case_NN of_IN bacterial_JJ superantigens_NNS (_( e.g._FW ,_, toxic_JJ shock_NN syndrome_NN toxin_NN 1_CD [_SYM TSST-1_NP ]_SYM )_) ._SENT The_DT cytokine_NN ,_, gamma_NN interferon_NN (_( IFN-gamma_NP )_) ,_, produced_VBN by_IN these_DT activated_VBN T_NN cells_NNS reduced_VBD the_DT level_NN of_IN mortality_NN and_CC joint_JJ destruction_NN in_IN a_DT mouse_NN model_NN of_IN group_NN B_NP Streptococcus_NP when_WRB delivered_VBN 18_CD h_NN after_IN bacterial_JJ inoculation_NN ._SENT However_RB ,_, when_WRB S._NP aureus_NN was_VBD used_VBN as_IN the_DT infecting_VBG organism_NN in_IN this_DT model_NN ,_, IFN-gamma_NP increased_VBD the_DT frequency_NN and_CC severity_NN of_IN septic_JJ arthritis_NN while_IN simultaneously_RB protecting_VBG mice_NNS from_IN septicemia_NN ._SENT Also_RB ,_, it_PP has_VBZ been_VBN found_VBN in_IN a_DT recent_JJ study_NN in_IN mice_NNS that_IN a_DT high_JJ level_NN of_IN IFN-gamma_NP (_( a_DT Th1_JJ cytokine_NN )_) plays_VBZ a_DT detrimental_JJ role_NN in_IN staphylococcal_JJ infection_NN and_CC that_DT IL-4_NN and_CC IL-10_NP ,_, both_CC being_VBG Th2_JJ cytokines_NNS ,_, are_VBP involved_VBN in_IN host_NN resistance_NN to_TO infection_NN through_IN regulation_NN of_IN IFN-gamma_NP ._SENT However_RB ,_, the_DT necessity_NN of_IN the_DT Th2_NP response_NN to_TO clear_JJ S._NP aureus_NN infection_NN has_VBZ lately_RB been_VBN questioned_VBN in_IN a_DT study_NN utilizing_VBG IL-4-deficient_JJ mice_NNS ._SENT It_PP seems_VBZ that_IN a_DT Th2_JJ response_NN is_VBZ required_VBN for_IN S._NP aureus_NN infection_NN clearance_NN only_RB in_IN certain_JJ mice_NNS ,_, depending_VBG on_IN their_PP$ genetic_JJ background_NN ._SENT Therefore_RB ,_, the_DT exact_JJ role_NN of_IN T_NN cells_NNS in_IN host_NN tissue_NN damage_NN and_CC infection_NN clearance_NN is_VBZ still_RB being_VBG elucidated_VBN ._SENT Under_IN most_JJS circumstances_NNS ,_, the_DT host_NN is_VBZ able_JJ to_TO mount_VB a_DT protective_JJ inflammatory_JJ response_NN that_WDT contains_VBZ the_DT invading_VBG pathogen_NN and_CC resolves_VBZ the_DT infection_NN ._SENT However_RB ,_, when_WRB the_DT infection_NN is_VBZ not_RB quickly_RB cleared_VBN by_IN the_DT host_NN ,_, the_DT potent_JJ activation_NN of_IN the_DT immune_JJ response_NN with_IN the_DT associated_VBN high_JJ levels_NNS of_IN cytokines_NNS and_CC reactive_JJ oxygen_NN species_NN leads_VBZ to_TO joint_JJ destruction_NN ._SENT High_JJ cytokine_NN concentrations_NNS increase_VBP the_DT release_NN of_IN host_NN matrix_NN metalloproteinases_NNS (_( including_VBG stromelysin_NN and_CC gelatinase_NN A/B_NN )_) and_CC other_JJ collagen-degrading_NN enzymes_NNS ._SENT When_WRB monoclonal_NN antibodies_NNS or_CC steroids_NNS attenuate_VBP these_DT cytokines_NNS ,_, cartilage_NN degradation_NN is_VBZ minimized_VBN ._SENT The_DT joint_NN is_VBZ further_RBR damaged_VBN by_IN the_DT release_NN of_IN lysosomal_JJ enzymes_NNS and_CC bacterial_JJ toxins_NNS ._SENT Host_NN proteoglycans_NNS are_VBP initially_RB degraded_VBN ,_, and_CC this_DT is_VBZ followed_VBN by_IN collagen_NN degradation_NN ._SENT In_IN fact_NN ,_, the_DT polymorphonuclear_JJ response_NN with_IN subsequent_JJ release_NN of_IN these_DT proteolytic_JJ enzymes_NNS can_MD lead_VB to_TO permanent_JJ destruction_NN of_IN intra-articular_JJ cartilage_NN and_CC subchondral_JJ bone_NN loss_NN in_IN as_RB little_JJ as_IN 3_CD days_NNS ._SENT Metalloproteinases_NNS and_CC the_DT antigen-induced_JJ inflammatory_JJ response_NN may_MD persist_VB and_CC continue_VB to_TO damage_VB the_DT joint_JJ architecture_NN even_RB after_IN the_DT infection_NN has_VBZ been_VBN cleared_VBN ._SENT The_DT infectious_JJ process_NN induces_VBZ a_DT joint_JJ effusion_NN that_WDT increases_VBZ intra-articular_JJ pressure_NN ,_, mechanically_RB impeding_VBG blood_NN and_CC nutrient_JJ supply_NN to_TO the_DT joint_NN ._SENT Thus_RB ,_, increased_VBN pressure_NN destroys_VBZ the_DT synovium_NN and_CC cartilage_NN ._SENT Because_IN of_IN the_DT proximity_NN of_IN the_DT epiphyseal_JJ growth_NN plate_NN to_TO the_DT joint_JJ ,_, direct_JJ extension_NN of_IN a_DT joint_JJ infection_NN to_TO any_DT of_IN the_DT articulating_VBG bones_NNS may_MD lead_VB to_TO decreased_VBN bone_NN growth_NN in_IN infants_NNS and_CC children_NNS ._SENT While_IN bone_NN mineralization_NN is_VBZ preserved_VBN ,_, cartilage_NN destruction_NN causes_VBZ joint_JJ space_NN narrowing_NN and_CC erosive_JJ damage_NN to_TO the_DT cartilage_NN and_CC bone_NN if_IN left_VBN untreated_JJ ._SENT In_IN addition_NN ,_, the_DT infection_NN can_MD spread_VB to_TO surrounding_VBG soft_JJ tissue_NN ,_, form_NN sinus_NN tracts_NNS ,_, and_CC disrupt_VB ligaments_NNS and_CC tendons_NNS in_IN the_DT untreated_JJ state_NN ._SENT While_IN bacterial_JJ attachment_NN proteins_NNS promote_VBP colonization_NN and_CC initiate_VB the_DT infectious_JJ process_NN ,_, a_DT number_NN of_IN bacterial_JJ products_NNS activate_VBP the_DT host_NN immune_JJ response_NN and_CC increase_NN tissue_NN damage_NN in_IN cases_NNS of_IN septic_JJ arthritis_NN ._SENT S._NP aureus_NN has_VBZ a_DT large_JJ variety_NN of_IN factors_NNS that_WDT have_VBP been_VBN implicated_VBN in_IN host_NN virulence_NN ._SENT Many_JJ of_IN these_DT factors_NNS have_VBP been_VBN tested_VBN for_IN their_PP$ ability_NN to_TO increase_VB the_DT morbidity_NN and_CC mortality_NN associated_VBN with_IN acute_JJ septic_JJ arthritis_NN ._SENT Most_JJS studies_NNS evaluating_VBG the_DT potential_JJ role_NN of_IN these_DT bacterial_JJ products_NNS have_VBP been_VBN performed_VBN using_VBG the_DT murine_JJ model_NN of_IN septic_JJ arthritis_NN ._SENT During_IN acute_JJ septic_JJ arthritis_NN ,_, the_DT innate_JJ immune_JJ system_NN responds_VBZ to_TO the_DT presence_NN of_IN the_DT peptidoglycan_JJ wall_NN (_( via_IN N-formylmethionine_JJ proteins_NNS and_CC teichoic_JJ acids_NNS )_) of_IN S._NP aureus_NN to_TO produce_VB proinflammatory_JJ cytokines_NNS (_( such_JJ as_IN IL-1beta_NP ,_, IL-6_NP ,_, and_CC TNF-alpha_NP )_) and_CC C-reactive_JJ protein_NN ._SENT Bacterial_JJ DNA_NN (_( specifically_RB unmethylated_JJ CpG_NP motifs_NNS )_) also_RB elicits_VBZ an_DT intense_JJ inflammatory_JJ response_NN ._SENT When_WRB bacterial_JJ DNA_NN from_IN S._NP aureus_NN or_CC E._NP coli_NNS or_CC synthetic_JJ ,_, unmethylated_JJ oligonucleotides_NNS containing_VBG CpG_NP motifs_NNS were_VBD injected_VBN into_IN the_DT knee_NN joint_NN of_IN mice_NNS ,_, arthritis_NN developed_VBD quickly_RB and_CC lasted_VBD up_RP to_TO 14_CD days_NNS ,_, while_IN methylated_VBN DNA_NN had_VBD no_DT significant_JJ effect_NN ._SENT Also_RB ,_, the_DT affected_JJ tissue_NN was_VBD characterized_VBN by_IN monocyte_NN and_CC macrophage_NN influx_NN with_IN the_DT release_NN of_IN their_PP$ associated_JJ cytokines_NNS and_CC chemokines_NNS and_CC the_DT absence_NN of_IN T_NN cells_NNS ._SENT It_PP has_VBZ been_VBN noted_VBN that_IN bacterial_JJ superantigens_NNS such_JJ as_IN staphylococcal_JJ TSST-1_NP and_CC enterotoxins_NNS may_MD play_VB a_DT major_JJ role_NN in_IN the_DT potent_JJ activation_NN of_IN the_DT host_NN inflammatory_JJ response_NN ,_, thereby_RB increasing_VBG the_DT mortality_NN rates_NNS and_CC exacerbating_VBG host_NN inflammatory-cell_NN invasion_NN ,_, cytokine_NN release_NN ,_, and_CC joint_JJ degradation_NN ._SENT Most_JJS animals_NNS infected_VBN with_IN strains_NNS of_IN S._NP aureus_NN isogenic_NN for_IN TSST-1_NP or_CC enterotoxins_NNS (_( A_DT through_IN D_NP )_) developed_VBD frequent_JJ and_CC severe_JJ arthritis_NN ._SENT However_RB ,_, most_JJS animals_NNS (_( 80_CD %_NN )_) infected_VBN with_IN strains_NNS devoid_JJ of_IN these_DT toxins_NNS had_VBD no_DT symptoms_NNS and_CC the_DT animals_NNS with_IN symptoms_NNS had_VBD only_RB mild_JJ or_CC transient_JJ arthritis_NN infections_NNS ._SENT Also_RB ,_, vaccination_NN with_IN a_DT recombinant_JJ form_NN of_IN staphylococcal_JJ enterotoxin_NN A_DT devoid_JJ of_IN superantigenicity_NN was_VBD able_JJ to_TO generate_VB significant_JJ protection_NN from_IN S._NP aureus_NN sepsis_NN in_IN mice_NNS ._SENT Superantigens_NNS act_VBP by_IN binding_VBG to_TO the_DT conserved_VBN lateral_JJ regions_NNS of_IN the_DT host_NN major_JJ histocompatibility_NN complex_NN class_NN II_NP molecule_NN and_CC T-cell_NN receptor_NN ._SENT While_IN only_RB approximately_RB 1_CD in_IN 10_CD 4_CD T_NN cells_NNS are_VBP activated_VBN during_IN normal_JJ presentation_NN of_IN a_DT nonself_NN antigen_NN ,_, a_DT superantigen_NN may_MD activate_VB 2_CD to_TO 20_CD %_NN of_IN all_DT T_NN cells_NNS ._SENT These_DT activated_VBN T_NN cells_NNS are_VBP then_RB able_JJ to_TO increase_VB the_DT release_NN of_IN a_DT number_NN of_IN cytokines_NNS ,_, such_JJ as_IN IL-2_NP ,_, IFN-gamma_NP ,_, and_CC TNF-alpha_NP ._SENT This_DT upregulated_JJ production_NN of_IN cytokines_NNS causes_VBZ a_DT significant_JJ systemic_JJ toxicity_NN and_CC suppression_NN of_IN the_DT adaptive_JJ immune_JJ responses_NNS and_CC inhibits_VBZ plasma_NN cell_NN differentiation_NN ._SENT Also_RB ,_, the_DT stimulated_VBN T_NN cells_NNS proliferate_VBP and_CC then_RB rapidly_RB disappear_VB ,_, apparently_RB due_JJ to_TO apoptosis_NN ._SENT Therefore_RB ,_, immune_JJ suppression_NN may_MD be_VB due_JJ to_TO generalized_VBN immunosuppression_NN and_CC T-cell_NN deletion_NN ._SENT Human_NP B_NP cells_NNS are_VBP also_RB stimulated_VBN by_IN these_DT staphylococcal_JJ superantigens_NNS ._SENT Besides_IN the_DT role_NN that_IN superantigens_NNS play_VBP in_IN the_DT mortality_NN and_CC morbidity_NN associated_VBN with_IN septic_JJ arthritis_NN ,_, other_JJ staphylococcal_JJ toxins_NNS may_MD also_RB contribute_VB to_TO the_DT disease_NN process_NN ._SENT One_CD study_NN was_VBD able_JJ to_TO demonstrate_VB that_DT alpha-hemolysin_NN was_VBD a_DT significant_JJ mediator_NN of_IN virulence_NN in_IN arthritis_NN ._SENT Alpha-hemolysin_NP is_VBZ secreted_VBN as_IN a_DT monomer_NN that_WDT attaches_VBZ to_TO host_VB membranes_NNS and_CC polymerizes_VBZ into_IN a_DT hexameric_JJ ring_NN channel_NN ._SENT While_IN this_DT hemolysin_NN binds_VBZ to_TO human_JJ erythrocytes_NNS in_IN a_DT nonspecific_JJ manner_NN ,_, it_PP can_MD still_RB mediate_VB significant_JJ host_NN cell_NN lysis_NN when_WRB produced_VBN in_IN high_JJ concentrations_NNS in_IN the_DT infection_NN environment_NN ._SENT Also_RB ,_, alpha-hemolysin_NN promotes_VBZ significant_JJ blood_NN coagulation_NN by_IN neutrophil_JJ adhesion_NN ,_, platelet_NN aggregation_NN (_( via_IN a_DT fibrinogen-dependent_JJ mechanism_NN )_) ,_, and_CC its_PP$ nonlytic_JJ attack_NN on_IN human_JJ platelets_NNS ._SENT In_IN addition_NN ,_, this_DT hemolysin_NN can_MD form_VB channels_NNS in_IN nucleated_VBN cells_NNS (_( e.g._FW ,_, endothelial_JJ cells_NNS )_) through_IN which_WDT calcium_NN ions_NNS freely_RB pass_VBP ._SENT The_DT calcium_NN influx_NN is_VBZ responsible_JJ for_IN the_DT vasoregulatory_JJ process_NN and_CC inflammatory-_NN response_NN disturbances_NNS seen_VBN in_IN severe_JJ infection_NN ._SENT Lastly_RB ,_, alpha-hemolysin_NN interferes_VBZ with_IN lymphocyte_NN DNA_NN replication_NN ._SENT These_DT multiple_JJ effects_NNS of_IN alpha-hemolysin_NN on_IN the_DT host_NN contribute_VB to_TO the_DT vascular_JJ disturbances_NNS and_CC immunodeficiency_NN seen_VBN in_IN staphylococcal_JJ infections_NNS ._SENT The_DT pathogenic_JJ properties_NNS of_IN alpha-hemolysin_NN were_VBD recently_RB found_VBN to_TO only_RB occur_VB when_WRB another_DT staphylococcal_JJ toxin_NN ,_, the_DT leukocyte-specific_JJ gamma-toxin_NN ,_, was_VBD also_RB present_JJ in_IN the_DT infecting_VBG strain_NN ._SENT Gamma-hemolysin_NP (_( HlgAB_NP and_CC HlgCB_NP )_) and_CC a_DT related_JJ S._NP aureus_NN leukocidin_NN (_( LukSF-PV_NP )_) specifically_RB lyse_VB leukocytes_NNS ._SENT Each_DT of_IN these_DT toxins_NNS is_VBZ composed_VBN of_IN an_DT interchangeable_JJ two-component_JJ system_NN ._SENT The_DT active_JJ toxin_NN is_VBZ formed_VBN by_IN taking_VBG one_CD protein_NN from_IN the_DT S-component_NP family_NN (_( LukS-PV_NP ,_, HlgA_NP ,_, and_CC HlgC_NP )_) and_CC one_CD from_IN the_DT F-component_JJ family_NN (_( LukF-PV_NP and_CC HlgB_NP )_) ._SENT The_DT S_NP component_NN is_VBZ most_RBS probably_RB responsible_JJ for_IN the_DT specific_JJ cytopathic_JJ effect_NN of_IN each_DT of_IN the_DT toxins_NNS ,_, while_IN the_DT F_NN component_NN is_VBZ responsible_JJ for_IN the_DT common_JJ leukocyte_NN binding_VBG activity_NN ._SENT While_IN LukF_NP and_CC HlgA_NP proteins_NNS show_VBP very_RB strong_JJ similarity_NN ,_, they_PP are_VBP encoded_VBN on_IN different_JJ gene_NN loci_NNS ._SENT Since_IN these_DT cytotoxins_NNS specifically_RB interact_VBP and_CC lyse_VBP leukocytes_NNS ,_, they_PP contribute_VBP to_TO the_DT inhibition_NN of_IN infection_NN clearance_NN by_IN the_DT host_NN immune_JJ system_NN ,_, thereby_RB enabling_VBG staphylococcal_JJ species_NNS to_TO persist_VB ._SENT Therefore_RB ,_, it_PP is_VBZ the_DT combined_JJ effects_NNS of_IN the_DT hemolysin_NN and_CC leukotoxins_NNS that_WDT increase_VBP the_DT ability_NN of_IN S._NP aureus_NN to_TO cause_VB acute_JJ septic_JJ arthritis_NN ._SENT These_DT factors_NNS enable_VBP the_DT host_NN to_TO mount_VB a_DT protective_JJ inflammatory_JJ response_NN that_WDT contains_VBZ this_DT pathogen_NN and_CC often_RB resolves_VBZ the_DT infection_NN ._SENT However_RB ,_, when_WRB the_DT infection_NN is_VBZ not_RB cleared_VBN by_IN the_DT host_NN innate_JJ immune_JJ system_NN ,_, S._NP aureus_NN is_VBZ well_RB equipped_VBN to_TO persist_VB by_IN possessing_VBG a_DT number_NN of_IN virulence_NN factors_NNS and_CC strategies_NNS ,_, including_VBG but_CC not_RB limited_VBN to_TO invading_VBG and_CC surviving_VBG in_IN mammalian_JJ cells_NNS ,_, hiding_VBG within_IN a_DT biofilm_NN ,_, or_CC producing_VBG a_DT thick_JJ ,_, antiphagocytic_JJ capsule_NN ._SENT The_DT difficulty_NN in_IN treating_VBG septic_JJ arthritis_NN and_CC the_DT ability_NN of_IN the_DT bacteria_NNS to_TO evade_VB clearance_NN by_IN the_DT host_NN immune_JJ response_NN reside_VB in_IN a_DT number_NN of_IN staphylococcal_JJ defense_NN mechanisms_NNS ._SENT Such_JJ characteristics_NNS are_VBP expressed_VBN at_IN both_CC the_DT cellular_JJ and_CC matrical_JJ levels_NNS ._SENT As_IN mentioned_VBN above_IN ,_, protein_NN A_NP is_VBZ bound_VBN covalently_RB to_TO the_DT outer_JJ peptidoglycan_NN layer_NN of_IN their_PP$ cell_NN walls_NNS ._SENT This_DT receptor_NN binds_VBZ to_TO the_DT Fc_NP portion_NN of_IN immunoglobulin_NN G_NN and_CC presents_VBZ the_DT Fab_NP fragment_NN of_IN the_DT antibody_NN to_TO the_DT external_JJ environment_NN ._SENT Therefore_RB ,_, the_DT Fc_NP portion_NN is_VBZ unable_JJ to_TO either_DT bind_NN complement_VB or_CC signal_VB polymorphonuclear_JJ leukocytes_NNS ,_, thereby_RB interfering_VBG with_IN staphylococcal_JJ opsonization_NN and_CC phagocytosis_NN ._SENT This_DT interference_NN has_VBZ been_VBN demonstrated_VBN in_IN vitro_NN and_CC in_IN animal_JJ models_NNS with_IN subcutaneous_JJ abscesses_NNS and_CC peritonitis_NN ._SENT Also_RB ,_, protein_NN A_DT coats_NNS the_DT staphylococcal_JJ cell_NN in_IN a_DT coat_NN of_IN host_NN Fab_NP fragments_VBZ ,_, and_CC the_DT ability_NN of_IN the_DT immune_JJ system_NN to_TO recognize_VB the_DT pathogen_NN as_IN nonself_NN is_VBZ hindered_VBN ._SENT The_DT importance_NN of_IN protein_NN A_DT in_IN S._NP aureus_NN septic_JJ arthritis_NN was_VBD demonstrated_VBN in_IN a_DT recent_JJ study_NN in_IN which_WDT strains_NNS that_WDT obtained_VBD this_DT virulence_NN factor_NN caused_VBD greater_JJR inflammation_NN and_CC cartilage_NN destruction_NN ._SENT Capsular_NN polysaccharide_NN may_MD interfere_VB with_IN opsonization_NN and_CC phagocytosis_NN ._SENT Among_IN the_DT 11_CD reported_JJ serotypes_NNS ,_, capsule_NN types_NNS 5_CD and_CC 8_CD (_( microcapsule_NN producers_NNS )_) comprise_VBP the_DT vast_JJ majority_NN (_( 75_CD to_TO 94_CD %_NN )_) of_IN clinical_JJ isolates_NNS ._SENT The_DT capsule_NN of_IN these_DT two_CD serotypes_NNS is_VBZ much_RB smaller_JJR than_IN the_DT capsule_NN of_IN other_JJ serotypes_NNS of_IN S._NP aureus_NN (_( such_JJ as_IN capsule_NN type_NN 1_CD )_) or_CC pathogenic_JJ species_NNS such_JJ as_IN Streptococcus_NP pneumoniae_NNS ._SENT Unencapsulated_JJ and_CC microencapsulated_JJ strains_NNS demonstrated_VBD a_DT high_JJ rate_NN of_IN serum_NN clearance_NN compared_VBN to_TO fully_RB encapsulated_VBN strains_NNS ._SENT Therefore_RB ,_, the_DT role_NN of_IN capsular_NN polysaccharide_NN in_IN opsonization_NN and_CC phagocytosis_NN was_VBD questioned_VBN ._SENT However_RB ,_, the_DT thin_JJ capsule_NN may_MD be_VB necessary_JJ in_IN early_JJ bone_NN infection_NN stages_NNS in_IN order_NN to_TO allow_VB the_DT interaction_NN of_IN staphylococcal_JJ adhesion_NN factors_NNS with_IN host_NN proteins_NNS (_( such_JJ as_IN fibrin_NN and_CC fibronectin_NN )_) ._SENT In_IN one_CD study_NN ,_, it_PP was_VBD shown_VBN that_IN a_DT small_JJ capsule_NN was_VBD necessary_JJ for_IN fibroblast_NN attachment_NN by_IN protein_NN A_DT of_IN S._NP aureus_NN and_CC that_IN a_DT fully_RB encapsulated_VBN strain_NN reduced_VBD the_DT binding_JJ efficiency_NN ._SENT In_IN another_DT study_NN ,_, the_DT thin_JJ capsule_NN was_VBD shown_VBN to_TO be_VB necessary_JJ for_IN binding_VBG to_TO bone_VB collagen_NN type_NN 1_CD ,_, since_IN high_JJ capsular_NN expression_NN actually_RB inhibited_VBD binding_VBG ._SENT Once_RB these_DT microorganisms_NNS adhere_VBP to_TO solid_JJ surfaces_NNS (_( such_JJ as_IN bone_NN )_) ,_, both_CC in_IN vitro_NN and_CC in_IN vivo_RB ,_, staphylococci_NNS produce_VBP larger_JJR quantities_NNS of_IN cell-associated_JJ capsule_NN than_IN do_VB those_DT grown_VBN in_IN liquid_JJ cultures_NNS ._SENT Specifically_RB ,_, type_NN 5_CD and_CC type_VB 8_CD capsule_NN production_NN is_VBZ strongly_RB upregulated_JJ during_IN postexponential_JJ growth_NN (_( i.e._FW ,_, after_IN adhesion_NN and_CC colonization_NN )_) ._SENT This_DT upregulated_JJ capsule_NN production_NN makes_VBZ them_PP resistant_JJ to_TO antimicrobial_JJ treatment_NN and_CC host_NN immune_JJ clearance_NN ._SENT Therefore_RB ,_, once_RB staphylococcal_JJ adherence_NN proteins_NNS establish_VB the_DT infection_NN ,_, the_DT pathogen_NN enters_VBZ the_DT postexponential_JJ growth_NN phase_NN and_CC begins_VBZ producing_VBG a_DT thicker_JJR capsule_NN that_WDT covers_VBZ and_CC hides_VBZ the_DT highly_RB immunogenic_JJ adherence_NN proteins_NNS ._SENT This_DT thicker_JJR type_NN 5_CD and_CC type_VB 8_CD capsule_NN is_VBZ serum_NN resistant_JJ through_IN inhibition_NN of_IN phagocytosis_NN and_CC opsonization_NN ._SENT The_DT effect_NN of_IN the_DT staphylococcal_JJ polysaccharide_NN microcapsule_NN in_IN murine_JJ arthritis_NN was_VBD recently_RB explored_VBN ._SENT In_IN this_DT study_NN ,_, strains_NNS expressing_VBG type_NN 5_CD capsule_NN were_VBD shown_VBN to_TO cause_VB a_DT higher_JJR rate_NN of_IN mortality_NN ,_, a_DT higher_JJR frequency_NN of_IN arthritis_NN ,_, and_CC a_DT more_RBR severe_JJ form_NN of_IN the_DT disease_NN compared_VBN to_TO capsule_NN mutants_NNS ._SENT In_IN a_DT clinical_JJ trial_NN ,_, a_DT vaccine_NN (_( Staph_NN Vax_NP )_) that_WDT consists_VBZ of_IN isolated_JJ type_NN 5_CD and_CC 8_CD capsular_NN polysaccharides_NNS was_VBD able_JJ to_TO significantly_RB reduce_VB infection_NN rates_NNS (_( by_IN 57_CD %_NN )_) in_IN a_DT high-risk_JJ population_NN for_IN as_RB long_JJ as_IN 10_CD months_NNS ._SENT As_RB mentioned_VBN above_RB ,_, S._NP aureus_NN also_RB survives_VBZ intracellularly_RB after_IN internalization_NN by_IN cultured_JJ osteoblasts_NNS ._SENT Type_NN 5_CD capsule_NN production_NN by_IN in_IN vivo-grown_JJ S._NP aureus_NN (_( i.e._FW ,_, internalized_VBN in_IN cultured_JJ osteoblasts_NNS )_) was_VBD recently_RB shown_VBN to_TO be_VB upregulated_VBN compared_VBN to_TO that_DT by_IN S._NP aureus_NN grown_VBN in_IN vitro_NN ._SENT Therefore_RB ,_, the_DT capsule_NN may_MD not_RB only_RB resist_VB phagocytosis_NN and_CC opsonization_NN but_CC may_MD also_RB contribute_VB to_TO intracellular_JJ survival_NN ._SENT In_IN summary_NN ,_, S._NP aureus_NN infects_VBZ and_CC elicits_VBZ a_DT strong_JJ native_JJ immune_JJ response_NN ,_, cytokine_NN release_NN ,_, and_CC high_JJ T-cell_NN activation_NN ._SENT This_DT pathogen_NN is_VBZ able_JJ to_TO use_VB a_DT number_NN of_IN immunoavoidance_NN strategies_NNS during_IN this_DT time_NN while_IN the_DT host_NN immune_JJ system_NN simultaneously_RB causes_VBZ damage_NN to_TO "_`` self_JJ "_'' tissues_NNS and_CC blood_NN vessels_NNS in_IN the_DT area_NN of_IN infection_NN ._SENT This_DT damage_NN may_MD cause_VB local_JJ circulatory_JJ and_CC immune_JJ system_NN compromise_NN ._SENT The_DT high_JJ T-cell_NN activation_NN eventually_RB results_VBZ in_IN apoptosis_NN and_CC a_DT weakened_JJ immune_JJ system_NN ,_, enabling_VBG the_DT pathogen_NN to_TO effectively_RB produce_VB a_DT sustained_JJ and_CC destructive_JJ infection_NN ._SENT While_IN the_DT bacterial_JJ products_NNS discussed_VBD above_RB have_VB been_VBN shown_VBN to_TO increase_VB joint_JJ damage_NN in_IN acute_JJ septic_JJ arthritis_NN ,_, many_DT more_JJR S._NP aureus_NN virulence_NN factors_NNS have_VBP not_RB yet_RB been_VBN tested_VBN ._SENT Therefore_RB ,_, we_PP would_MD expect_VB that_DT number_NN of_IN factors_NNS implicated_VBN as_IN playing_VBG a_DT role_NN in_IN septic_JJ arthritis_NN would_MD undoubtedly_RB increase_VB ,_, and_CC their_PP$ relative_JJ roles_NNS will_MD be_VB more_RBR clearly_RB elucidated_VBN in_IN future_JJ studies_NNS ._SENT The_DT interaction_NN of_IN the_DT bacteria_NNS and_CC host_NN is_VBZ of_IN utmost_JJ importance_NN in_IN the_DT initiation_NN and_CC prolongation_NN of_IN infection_NN and_CC cartilage_NN damage_NN ._SENT There_EX is_VBZ a_DT subtle_JJ balance_NN between_IN an_DT effective_JJ immune_JJ response_NN to_TO eliminate_VB the_DT infecting_VBG organism_NN from_IN the_DT host_NN and_CC the_DT overactivation_NN of_IN this_DT response_NN that_WDT causes_VBZ the_DT majority_NN of_IN infection-related_JJ joint_JJ destruction_NN ._SENT Therefore_RB ,_, care_NN must_MD be_VB exercised_VBN and_CC further_JJR studies_NNS must_MD be_VB performed_VBN in_IN regard_NN to_TO using_VBG agents_NNS that_WDT suppress_VBP the_DT inflammatory_JJ response_NN in_IN the_DT treatment_NN of_IN septic_JJ arthritis_NN ._SENT Gonococcal_JJ arthritis_NN occurs_VBZ in_IN approximately_RB 42_CD to_TO 85_CD %_NN of_IN patients_NNS with_IN disseminated_VBN gonococcal_JJ infection_NN (_( DGI_NP )_) and_CC begins_VBZ with_IN a_DT localized_JJ mucosal_JJ infection_NN ._SENT DGI-producing_NN strains_NNS are_VBP unusually_RB sensitive_JJ to_TO in_IN vitro_NN killing_VBG by_IN penicillin_NN G_NN and_CC possess_VB unique_JJ nutritional_JJ requirements_NNS for_IN arginine_NN ,_, hypoxanthine_NN ,_, and_CC uracil_NN ._SENT N._NP gonorrhoeae_NNS possesses_VBZ a_DT number_NN of_IN virulence_NN factors_NNS ._SENT It_PP is_VBZ the_DT combined_JJ effects_NNS of_IN these_DT factors_NNS ,_, their_PP$ phase_NN and_CC antigenic_JJ variation_NN ,_, and_CC properties_NNS of_IN the_DT host_NN immune_JJ response_NN that_WDT enable_VBP this_DT pathogen_NN to_TO persist_VB and_CC allow_VB the_DT localized_JJ infection_NN to_TO become_VB DGI_NP ._SENT N._NP gonorrhoeae_NNS possesses_VBZ a_DT number_NN of_IN cell_NN surface_NN structures_NNS that_WDT have_VBP been_VBN implicated_VBN in_IN virulence_NN ._SENT Initial_JJ attachment_NN to_TO host_NN epithelium_NN is_VBZ mediated_VBN by_IN long_JJ ,_, hair-like_JJ protein_NN projections_NNS called_VBD pili_NN Phase_NP variation_NN ,_, i.e._FW ,_, the_DT question_NN of_IN whether_IN this_DT membrane_NN structure_NN is_VBZ assembled_VBN (_( Pil_NP +_SYM )_) or_CC not_RB (_( Pil_NP -_: )_) ,_, is_VBZ determined_VBN by_IN posttranslational_JJ proteolytic_JJ cleavage_NN ,_, variations_NNS in_IN homologous_JJ recombination_NN ,_, and_CC slipped-strand_NN DNA_NN replication_NN resulting_VBG in_IN frameshift_NN mutations_NNS ._SENT In_IN addition_NN ,_, the_DT antigenic_JJ character_NN of_IN the_DT pili_NN is_VBZ altered_VBN by_IN homologous_JJ recombination_NN between_IN coding_VBG regions_NNS for_IN the_DT various_JJ pilin_NN subunits_NN ._SENT Protein_NN I_PP is_VBZ the_DT main_JJ protein_NN on_IN the_DT outer_JJ membrane_NN ._SENT It_PP is_VBZ a_DT porin_NN that_WDT is_VBZ expressed_VBN in_IN two_CD different_JJ forms_NNS ,_, a_DT protein_NN IA_NN variant_NN that_WDT is_VBZ almost_RB always_RB associated_VBN with_IN disseminated_VBN infection_NN and_CC a_DT 